Tango Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
TNGX Nasdaq 2834 www.tangotx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tango Therapeutics, Inc.

Tango Therapeutics (TNGX) Has Striking Pancreatic Cancer Data. How Much Is Priced In? - Oct 20th, 2026 10:34 am
Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026 - Oct 16th, 2026 5:00 am
Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report? - Sep 10th, 2026 9:30 am
Tango Therapeutics (TNGX) At 3.7x P B As Pullback Tests Whether It Looks Pricey - Sep 4th, 2026 1:08 am
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 3rd, 2026 2:05 pm
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - Sep 1st, 2026 5:00 am
RVMD Secures FDA Win, Gets Nod for Rasonque in Pancreatic Cancer - Aug 27th, 2026 11:00 am
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses - Aug 12th, 2026 8:46 am
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights - Aug 11th, 2026 5:00 am
Tango Therapeutics Announces Executive Chair Transition - Aug 6th, 2026 4:24 pm
4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates - Aug 3rd, 2026 8:34 am
FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer - Jul 23rd, 2026 11:10 am
How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48% - Jul 22nd, 2026 7:55 am
Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues - Jul 15th, 2026 8:01 am
2 Monster Growth Stocks Analysts Think Can Reach New Highs - Jul 9th, 2026 11:54 am
Tango Therapeutics Rides a New Precision Oncology Trend in 2026 - Jul 2nd, 2026 8:50 am
Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026? - Jul 2nd, 2026 8:46 am
TNGX Stock Outlook Hinges on Vopimetostat and Key 2026 Catalysts - Jul 2nd, 2026 8:43 am